A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2006
12/12/2006	US7148226 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
12/12/2006	US7148225 Treating rheumatoid arthritis, psoriasis, reperfusion injury, cardiovascular , autoimmune, inflammatory disorders and bronchial asthma
12/12/2006	US7148224 Pyrazinone derivatives
12/12/2006	US7148223 4′-thio-L-xylo furanosyl nucleosides, precursors thereof, preparation and use thereof
12/12/2006	US7148222 Substituted pyrido-pyridazine derivatives which enhance cognition via the GABA-A receptors
12/12/2006	US7148221 Vanilloid receptor ligands and their use in treatments
12/12/2006	US7148220 Tyrosine kinase enzyme inhibitors as growth factor receptors and useful as antiproliferation agents
12/12/2006	US7148219 Biaryl heterocyclic compounds and methods of making and using the same
12/12/2006	US7148218 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors
12/12/2006	US7148216 Combinations of drugs for the treatment of neoplastic disorders
12/12/2006	US7148215 Prodrugs as antihistamines or anticarcinogenic agents
12/12/2006	US7148214 Antihistaminic spiro compounds
12/12/2006	US7148213 Steroids with fluoroalkyl groups as antigestation steroids used in gynecological treatment
12/12/2006	US7148212 Subjecting a supersaturated solution containing a steroid to wet milling while crystallizing, in order to obtain a primary particle suspension.
12/12/2006	US7148211 Improved water solubility; drug delivery; avoids irritation
12/12/2006	US7148210 Method of treating bone metastasis
12/12/2006	US7148208 For therapy and prophylaxis
12/12/2006	US7148207 For therapy of cancer; quick release tablet of fludarabine phosphate in a defined composition of residual contaminants
12/12/2006	US7148206 Methods and compositions for treating flaviviruses and pestiviruses
12/12/2006	US7148205 Intravascular delivery of non-viral nucleic acid
12/12/2006	US7148204 An antisense compound 8 to 30 nucleobases in length targeted to a 3'-untranslated region, a stop codon region, a coding region, or a 5'-untranslated region of a nucleic acid molecule encoding human bcl-x gene or protein
12/12/2006	US7148203 Plasmid for use in gene expression, mapping and mutagenesis; transposases
12/12/2006	US7148202 Receptor-mediated gene delivery using bacteriophage vectors
12/12/2006	US7148201 Use of human plasma hyaluronidase in cancer treatment
12/12/2006	US7148200 Adenocarcinogenic agent
12/12/2006	US7148198 Antibacterial agents
12/12/2006	US7148191 Antigenic composition
12/12/2006	US7148045 Complex multienzyme with loading domain linked to extension domains and adds a ketide for decarboxylation.
12/12/2006	US7148039 Protein derived composition for skin care using spider silk protein or an analog with adjuvants
12/12/2006	US7148028 For diagnosis, prognosis, prophylaxis
12/12/2006	US7147876 comprises Aloe vera, Vitamins, mineral concentrate, organic oils concentrate, Chinese herb, essential oil and spice; for medicinal/cosmetic use
12/12/2006	US7147874 Pharmaceutical composition for prevention and treatment of premature ejaculation and/or hypersensitivity of sexual stimulation
12/12/2006	US7147873 I2 and/or an iodophor to provide an available iodine concentration of at least 0.25 wt-%; a hydroxycarboxylic acid buffer; water; and a substantive film-forming polymer.
12/12/2006	US7147870 Osmotic device containing pseudoephedrine and an H1 antagonist
12/12/2006	US7147869 Rapidly disintegrating tablet comprising an acid-labile active ingredient
12/12/2006	US7147866 UV-absorbing lipid vesicles
12/12/2006	US7147864 Administering a wound healing agent containing selegiline and/or desmethylselegiline to a subject suffering from photodamaged skin, injury or wound, for a duration sufficient to promote epithelization of such wound
12/12/2006	US7147863 Preventing the induction of matrix metalloproteinases in skin by applying substances that block UVB radiation in the range of about 295-315 nm and block UVA radiation in the range of about 365-395 nm.
12/12/2006	US7147859 Application of phytosterols (and their isomers), folic acid, cyanocobalamin and pyridoxin in dietetic (alimentary) fibers
12/12/2006	US7147845 Antimicrobial silver ion complex resinates
12/12/2006	US7147844 System for stabilizing lacrimal fluid layer
12/12/2006	CA2451725C Therapeutic combinations for the treatment of hormone deficiencies
12/12/2006	CA2434726C Method of improving beef quality
12/12/2006	CA2347741C Thiazole-derivatives
12/12/2006	CA2342206C Microparticles
12/12/2006	CA2326716C Triazolopurine derivative, pharmaceutical composition containing the derivative, adenosine a3 receptor ligand, and remedy for asthma
12/12/2006	CA2314541C Use of 4,6-dimethoxy-indole 2-carboxylic acid or its derivatives to stimulate or induce hair growth and/or stop hair loss
12/12/2006	CA2305394C Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
12/12/2006	CA2303339C A pharmaceutical composition for treating dysmenorrhea and premature labor
12/12/2006	CA2300204C Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors
12/12/2006	CA2290531C Pharmaceutical formulation of omeprazole
12/12/2006	CA2286076C Use of 5ht3 antagonists for promoting intestinal lavage
12/12/2006	CA2278056C Gemcitabine derivatives
12/12/2006	CA2272366C Compositions containing an antifungal and a cationic agent
12/12/2006	CA2268314C Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems
12/12/2006	CA2266081C Process for producing ecteinascidin compounds
12/12/2006	CA2263166C Reducing toxic effects of carboplatin using dithioethers
12/12/2006	CA2257931C Modified form of the r(-)-n-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride
12/12/2006	CA2245926C 7-phenyl-1,4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing them
12/12/2006	CA2242618C Compositions comprising ultrapure pvp having an average molecular weight in the range of 7,000 to 12,000 daltons
12/12/2006	CA2234480C Colchicine and thiocolchicine derivatives with antiinflammatory and muscle relaxant activities
12/12/2006	CA2225284C Colchicine derivatives, the use thereof and formulations containing them
12/12/2006	CA2215680C Prilocaine and hydrofluorocarbon aerosol preparations
12/12/2006	CA2194220C Process for producing desulfated polysaccharide, and desulfated heparin
12/12/2006	CA2190851C Palladium catalyzed ring closure of triazolyl tryptamine
12/12/2006	CA2183331C Process for producing a sterile prednisolone gel
12/12/2006	CA2180624C Diphenyl-1,2,3-thiadiazoles as anti-inflammatory agents
12/12/2006	CA2162670C High dose formulations of mycophenolate mofetil, mycophenolic acid and ranolazine
12/12/2006	CA2159355C Method and composition for treatment of osteoporosis
12/12/2006	CA2154161C Therapeutic uses and delivery systems of dehydroepiandrosterone
12/12/2006	CA2153570C Pharmaceutical composition for treating nicotine dependence
12/12/2006	CA2147608C Topoisomerase ii inhibitors and therapeutic uses therefor
12/12/2006	CA2146248C Process for preparing 10-desacetylbaccatine iii
12/12/2006	CA2140106C Method of treating hyperproliferative vascular disease
12/12/2006	CA2121871C A prophylactic or therapeutic drug for renal diseases
12/12/2006	CA2098176C Angiotensin ii receptor blocking compositions
12/08/2006	CA2612994A1 Nanoparticulate and controlled release compositions comprising cefditoren
12/08/2006	CA2528849A1 Quinoline derivatives as antibacterial agents
12/07/2006	WO2006130697A1 Hmgb1 expression and protective role of semapimod in nec
12/07/2006	WO2006130688A2 Compounds for inhibiting cathepsin activity
12/07/2006	WO2006130686A2 Hcv protease inhibitors in combination with food
12/07/2006	WO2006130676A2 Inhibition of neuronal damage
12/07/2006	WO2006130673A1 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
12/07/2006	WO2006130672A1 Glucose inducible insulin expression and methods of treating diabetes
12/07/2006	WO2006130600A1 Compositions and methods for treating pain
12/07/2006	WO2006130588A1 Bicyclic 6-alkylidene-penems as class-d beta-lactamases inhibitors
12/07/2006	WO2006130553A2 Hcv protease inhibitors
12/07/2006	WO2006130532A2 Treatment of liver diseases in which iron plays a role in pathogenesis
12/07/2006	WO2006130522A2 Methods and compositions for managing psychotic disorders
12/07/2006	WO2006130501A2 Tigecycline and methods of preparing 9-nitrominocycline
12/07/2006	WO2006130500A2 Tigecycline and methods of preparing 9-aminominocycline
12/07/2006	WO2006130493A2 Heterocycles useful as modulators of ion channels
12/07/2006	WO2006130469A1 Stimulation of neurite outgrowth by small molecules
12/07/2006	WO2006130431A1 Methods of purifying tigecycline
12/07/2006	WO2006130418A1 Tigecycline and methods of preparation
12/07/2006	WO2006130403A1 Phenylalkyl substituted heteroaryl devivatives
12/07/2006	WO2006130399A2 Therapeutic combinations and methods including irm compounds
12/07/2006	WO2006130297A2 Solid forms of 1-( 5-(ih-i , 2 , 4 -triazol- 5 -yl)(1h-indazol-3-yl))-3-(2-piperidylethoxy)benzene
12/07/2006	WO2006130177A1 Particulate-stabilized injectable pharmaceutical compositions of posaconazole
12/07/2006	WO2006130174A2 Compositions comrising nebivolol

1 ... 3973 3974 3975 3976 3977 3978 3979 3980 3981 3982 3983 3984 3985 3986 3987 3988 3989 3990 3991 3992 3993 ... 7860